The world's largest condom manufacturer, Malaysia-listed Karex Bhd, plans to increase product prices by 20% to 30% and warns that further hikes may follow if supply chain disruptions persist. This situation highlights another instance where the Iran war has strained energy and petrochemical supplies in the Middle East, impacting global manufacturing supply chains.

According to reports, Karex CEO Goh Miah Kiat stated on April 21 that since the conflict escalated in late February, the company has faced significant cost increases for raw materials such as synthetic rubber and nitrile rubber, as well as packaging materials. At the same time, rising freight costs and shipping delays have led to customer inventories falling below normal levels, with global condom demand increasing by approximately 30% since the start of the year.

The dual pressures of supply constraints and surging demand pose a significant risk of shortages in the global condom market. Karex provides manufacturing services for major brands such as Durex and Trojan, and its clients also include the UK's National Health Service (NHS) and United Nations global aid programs. The company's pricing trends directly affect public health procurement costs worldwide.

Comprehensive cost increases make price hikes unavoidable. Goh Miah Kiat explained that the Iran war has disrupted petrochemical supply chains in the Middle East, leading to across-the-board rises in the company's raw material costs since the conflict began. These increases affect production materials like synthetic rubber and nitrile rubber, as well as packaging and lubricant materials such as aluminum foil and silicone oil. He stated:

"The situation is very fragile, prices are already high, and we have no choice but to pass these costs on to customers."

Karex produces over 5 billion condoms annually, making it the world's largest single manufacturer. The company plans to raise factory prices by 20% to 30% and has explicitly stated that further price increases may be necessary if supply chain disruptions continue. Karex is not alone in facing these challenges, as reports indicate that medical glove manufacturers and other companies are also dealing with this supply chain shock.

Surging demand combined with shipping delays continues to pressure the global condom market. While supply costs rise, demand has also shown unusual growth. Goh Miah Kiat noted that global condom demand has increased by about 30% this year, partly due to significant cuts in foreign aid spending by USAID last year, which led to substantial reductions in global public inventories and concentrated replenishment needs across various regions.

Shipping delays have further exacerbated supply-demand mismatches. Currently, shipment times from Karex to European and American markets have extended from approximately one month to nearly two months. Goh Miah Kiat mentioned that large quantities of condoms remain on vessels that haven't reached their destinations, while many developing countries face particularly tight inventories due to longer logistics cycles. He commented:

"Many condoms are still on ships and haven't reached their destinations, but demand is already urgent."

Despite ongoing external pressures, Goh Miah Kiat stated that current raw material reserves can support production for the coming months. The company is actively evaluating the feasibility of expanding production capacity to meet continuously rising market demand. However, time lags across the entire chain from raw material procurement to product delivery mean that supply tightness is unlikely to ease quickly in the short term. For public health programs and brand customers relying on Karex supplies, rising costs and extended delivery cycles will remain core challenges in the coming months.